Summit Therapeutics Inc (SMMT)
$10.49
Summit Therapeutics Inc (SMMT) Share Price Forecast
Currently 7 wall-street analysts regularly analyze the financials of Summit Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 7 analysts offering 12-month price forecasts for Summit Therapeutics Inc (SMMT) have a share price target of $10.67. This median of share price forecast represents a 1.72% upside from the latest price of $10.49 as on 26.07.24.
Summit Therapeutics Inc (SMMT) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Summit Therapeutics Inc (SMMT) share price will touch around $10.67 in next 12-months.
Summit Therapeutics Inc (SMMT) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Summit Therapeutics Inc's share price and its median forecast price. As on 26.07.24, the difference is -23.71%
Summit Therapeutics Inc (SMMT): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Summit Therapeutics Inc (SMMT) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Summit Therapeutics Inc (SMMT) is $10.67, offered by 7 analysts offering 12-month price forecasts.
Summit Therapeutics Inc (SMMT) has a maximum of 0.02 upside potential, based on 7 analysts offering 12-month price forecasts.
Based on 7 analysts tracking and researching Summit Therapeutics Inc (SMMT), 85.71% have a buy recommendation. Remaining 14.29% have either sell or hold recommendations.
The latest share price of Summit Therapeutics Inc (SMMT) is $10.49 as of 26/07/2024.
6 of total 7 analysts offering stock ratings for Summit Therapeutics Inc SMMT have recommended buy rating.
â‚ą0 US Stocks a/c Opening Fee